Firefly Neuroscience (AIFF) vs Intellinetics (INLX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Intellinetics (INLX) has outperformed Firefly Neuroscience (AIFF) over the past year, losing 50.9% versus a loss of 59.1%. Over five years, INLX leads with a +3.8% price change compared with -98.7% for AIFF. Intellinetics is the larger company by market cap ($24.3 million vs $19.0 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIFF | INLX |
|---|---|---|
| Share price | $1.21 | $5.40 |
| Market cap | $18.99M | $24.27M |
| 1-day change | -0.82% | +3.05% |
| YTD return | +38.64% | -32.33% |
| 1-year return | -59.06% | -50.91% |
| 5-year return | -98.71% | +3.84% |
| Forward P/E | — | 90.00 |
| EPS (TTM) | $-0.59 | $-0.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.15 | $11.75 |
| 52-week low | $0.62 | $4.51 |
| Distance from 52-week high | -61.59% | -54.04% |
| Average volume | 2.68M | 4.82K |
| Shares outstanding | 15.69M | 4.49M |
| Employees | 17 | 129 |
| Sector | Technology | Technology |
| Industry | Software - Application | Software - Application |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Firefly Neuroscience
AIFF stock →Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury.
Technology · Software - Application · 17 employees
About Intellinetics
INLX stock →Intellinetics, Inc. designs, develops, tests, markets, and licenses document services and software solutions in the United States.
Technology · Software - Application · 129 employees
AIFF vs INLX FAQ
Which is bigger, Firefly Neuroscience or Intellinetics?
Intellinetics (INLX) is larger, with a market capitalization of $24.27M compared with $18.99M for Firefly Neuroscience (AIFF).
Which stock has performed better over the past year, AIFF or INLX?
INLX returned -50.91% over the past 12 months, compared with -59.06% for AIFF (price return, excluding dividends). Past performance does not predict future results.
Are Firefly Neuroscience and Intellinetics in the same industry?
Yes. Both are classified in the Software - Application industry within the Technology sector.